Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation (EBUS-GA-MS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01430962 |
Recruitment Status :
Completed
First Posted : September 9, 2011
Last Update Posted : July 23, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Mediastinal Lymphadenopathies Mediastinal Masses Hilar Lymphadenopathies |
Study Type : | Observational |
Actual Enrollment : | 149 participants |
Time Perspective: | Prospective |
Official Title: | Randomized Controlled Trial Comparing Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) Performed Under General Anesthesia Versus Conscious Sedation |
Study Start Date : | November 2011 |
Actual Primary Completion Date : | July 2013 |
Actual Study Completion Date : | February 2014 |
Group/Cohort |
---|
General Anesthesia
Patients will receive Total Intravenous Anesthesia (TIVA) with a combination of Propofol, Ketamine and neuromuscular blockade by anesthesia. Either an LMA or an ETT will be used to secure airway.
|
Moderate Sedation
Patients will receive moderate sedation given by the physician performing EBUS with a combination of Versed and Fentanyl per hospital protocol.
|
- Diagnostic Yield [ Time Frame: 24 months ]
- Complications rate [ Time Frame: 24 months ]
- Time to recovery from anesthesia [ Time Frame: 24 months ]
- Tolerance to procedure [ Time Frame: 24 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All patients over the age of 18, evaluated by pulmonary physician that require EBUS TBNA for sampling of hilar and/or mediastinal lymphadenopathies or masses
- Patients should be considered eligible to undergo either CS or GA, without contraindications for either one of them, based on the assessment by the pulmonologist who will perform EBUS-TBNA
Exclusion Criteria:
- Pregnancy or breastfeeding women
- Patients deemed poor candidates for general anesthesia by the evaluating physician (e.g., severe coronary artery disease, COPD with FEV1 < 1 liter, uncontrolled hypertension, increased intracranial pressure, reaction to anesthetics)
- Previous reaction to medications routinely used in conscious sedation
- Patients with history of intolerance to either general anesthesia or conscious sedation
- Dementia or other severe cognitive impairment causing inability to understand or consent to the procedure and study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01430962
United States, Texas | |
Michael E. DeBakey VA Medical Center | |
Houston, Texas, United States, 77030 |
Principal Investigator: | Roberto F. Casal, MD | Baylor College of Medicine- Michael E. DeBakey VA Medical Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Roberto Casal, Assistant Professor of Medicine, Baylor College of Medicine |
ClinicalTrials.gov Identifier: | NCT01430962 |
Other Study ID Numbers: |
H-27545 |
First Posted: | September 9, 2011 Key Record Dates |
Last Update Posted: | July 23, 2015 |
Last Verified: | July 2015 |
EBUS mediastinal lymph nodes mediastinal masses anesthesia moderate sedation |
Lymphadenopathy Lymphatic Diseases |